Press Release discussing the financial results of first quarter ended as on June 30, 2026 is attached.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 24 Jul 2026, 12:59 PM IST · BSE ID: 53bc6f40-a21d-4697-bc47-39e30f8292c9
View Original BSE Filing (PDF)
💡
In Simple Terms
Acutaas Chemicals' first-quarter revenue and profit both increased significantly compared to the same period last year.
🤖 AI Summary
- Acutaas Chemicals' Q1 FY27 consolidated revenue from operations reached ₹3,297 mn, up 59.1% year-over-year.
- Net profit (PAT) for Q1 FY27 stood at ₹750 mn, marking a 70.4% increase compared to Q1 FY26.
- Gross margin improved to 57.9% in Q1 FY27 from 53.2% in Q1 FY26, a 466 basis points increase.
- EBITDA for the quarter was ₹1,131 mn, increasing 122.1% YoY, with EBITDA margin at 34.3%.
- Company received Great Place to Work certification and Responsible Care certification from Indian Chemical Council.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q1 FY27)
₹3,297 mn
59.1%
PAT (Q1 FY27)
₹750 mn
70.4%
Gross Margin (Q1 FY27)
57.9%
EBITDA (Q1 FY27)
₹1,131 mn
122.1%
EBITDA Margin (Q1 FY27)
34.3%
PAT Margin (Q1 FY27)
22.7%
🏢 How This Affects the Company
The company reported substantial growth in revenue from operations, indicating increased demand or sales volume for its pharmaceutical intermediates and speciality chemicals.
Net profit and EBITDA experienced significant year-over-year growth, leading to improved PAT and EBITDA margins, reflecting enhanced profitability and operational efficiency.
The Responsible Care certification indicates adherence to high standards of safety, health, and environmental performance, which can strengthen operational practices and reputation.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results press release.
👤
Who Is Affected
All shareholders are affected as these results provide an update on the company's financial health and operational performance for the first quarter of FY27.
🔍
Management Signal
Management expressed confidence in delivering 25% revenue growth for the full year with stable margins, indicating a focus on consistent performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — check for sustained YoY growth and margin trends.
Any updates on further certifications or industry recognition for operational standards.
Management commentary on the progress towards 25% full-year revenue growth.
LOW RISK
The filing reports strong Q1 FY27 financial results with no specific risks highlighted.
💡 Investor Takeaway
Acutaas Chemicals reported Q1 FY27 consolidated revenue from operations of ₹3,297 mn, up 59.1% YoY, and PAT of ₹750 mn, up 70.4% YoY. Gross margin improved to 57.9% and EBITDA margin to 34.3%.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from operations grew by 59.1% YoY to ₹3,297 mn in Q1 FY27, demonstrating strong sales performance.
- Net profit (PAT) increased by 70.4% YoY to ₹750 mn, reflecting improved profitability and margin expansion.
⚠️ Concerns
- QoQ revenue from operations decreased by 23.8% from ₹4,328 mn in Q4 FY26 to ₹3,297 mn in Q1 FY27.
- QoQ net profit (PAT) decreased by 44.2% from ₹1,343 mn in Q4 FY26 to ₹750 mn in Q1 FY27.
📅 Company Track Record
Acutaas Chemicals previously reported Q1 FY27 consolidated net profit of Rs. 7,497.24 lakhs (which converts to Rs. 749.724 million or ₹749.72 mn) up 68.30% YoY in a July 24, 2026 filing. The current press release states PAT at ₹750 mn, up 70.4% YoY. For FY26, the company approved audited results and recommended a Rs. 2.5/share dividend on 8,18,71,122 shares.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Acutaas Chemicals' consolidated revenue from operations in Q1 FY27?
Acutaas Chemicals reported consolidated revenue from operations of ₹3,297 mn for Q1 FY27, representing a 59.1% increase year-over-year.
What was Acutaas Chemicals' net profit (PAT) in Q1 FY27?
The consolidated net profit (PAT) for Acutaas Chemicals in Q1 FY27 was ₹750 mn, which is a 70.4% increase compared to Q1 FY26.
How did Acutaas Chemicals' EBITDA perform in Q1 FY27?
Acutaas Chemicals' EBITDA for Q1 FY27 was ₹1,131 mn, marking a 122.1% increase year-over-year. The EBITDA margin improved to 34.3%.
What certifications did Acutaas Chemicals receive as per the Q1 FY27 press release?
Acutaas Chemicals received Great Place to Work certification and the Responsible Care certification from the Indian Chemical Council during Q1 FY27.
Questions based on this BSE filing only. For information purposes.